Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10670911rdf:typepubmed:Citationlld:pubmed
pubmed-article:10670911lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10670911lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:10670911lifeskim:mentionsumls-concept:C0067762lld:lifeskim
pubmed-article:10670911pubmed:issue2lld:pubmed
pubmed-article:10670911pubmed:dateCreated2000-2-25lld:pubmed
pubmed-article:10670911pubmed:abstractTextIt is well established that serum total sialic acid (TSA) is elevated in patients with type-2 diabetes mellitus (NIDDM) compared to non-diabetics. However, it is not clear whether serum TSA is also elevated in type-1 diabetic patients (IDDM). Twenty-one type-1 patients were studied along with age and sex matched normal non-diabetic subjects (ten males and 11 females). Their ages were 24.8+/-3.4 years (20-30) and 23.5+/-3.9 years (18-30) respectively. The duration of diabetes mellitus was 12.6+/-6.7 years (1-24) with a HBA1c of 9.0+/-2.2% (6.0-14.9). There was no significant difference in serum TSA of the type-1 diabetic patients 689+/-107 mg/l versus 670+/-119 mg/l in the normal subjects. Nor was there a significant correlation between serum TSA with patient age (r = -0.31), urine albumin/creatinine ratio (ACR) (r = 0.25), HBA1c (r = 0.36), plasma random glucose (r = -0.04) or diabetes duration (r = -0.09) in the diabetic patients. However, there was a significant correlation between serum TSA and mean daily insulin dose (r = 0.51, P<0.02) and also serum cholesterol and triglyceride (r = 0.58, P<0.01 and r = 0.49, P<0.04, respectively) in the type-1 diabetic patients. In summary, we conclude that serum TSA is not elevated in young type-1 diabetic patients compared with normal age and sex matched control subjects. However, the relationship between serum TSA and serum lipids and also mean daily insulin dose merits further research.lld:pubmed
pubmed-article:10670911pubmed:languageenglld:pubmed
pubmed-article:10670911pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10670911pubmed:citationSubsetIMlld:pubmed
pubmed-article:10670911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10670911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10670911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10670911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10670911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10670911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10670911pubmed:statusMEDLINElld:pubmed
pubmed-article:10670911pubmed:monthFeblld:pubmed
pubmed-article:10670911pubmed:issn0168-8227lld:pubmed
pubmed-article:10670911pubmed:authorpubmed-author:WorsleyAAlld:pubmed
pubmed-article:10670911pubmed:authorpubmed-author:LumbPPlld:pubmed
pubmed-article:10670911pubmed:authorpubmed-author:CrookMMlld:pubmed
pubmed-article:10670911pubmed:authorpubmed-author:CartwrightKKlld:pubmed
pubmed-article:10670911pubmed:issnTypePrintlld:pubmed
pubmed-article:10670911pubmed:volume47lld:pubmed
pubmed-article:10670911pubmed:ownerNLMlld:pubmed
pubmed-article:10670911pubmed:authorsCompleteYlld:pubmed
pubmed-article:10670911pubmed:pagination119-22lld:pubmed
pubmed-article:10670911pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:meshHeadingpubmed-meshheading:10670911...lld:pubmed
pubmed-article:10670911pubmed:year2000lld:pubmed
pubmed-article:10670911pubmed:articleTitleSerum sialic acid in young type-1 diabetic patients.lld:pubmed
pubmed-article:10670911pubmed:affiliationDepartment of Chemical Pathology, Guy's and St Thomas' Hospital, London, UK.lld:pubmed
pubmed-article:10670911pubmed:publicationTypeJournal Articlelld:pubmed